Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Nov 23rd 2019, Crypto Chartbook – Why markets work

Why markets work We as humans are fooled by a brain that functions on comparison. However, based on the true principle, every moment is unique and we expand with every time increment into an absolutely new future (big bang theory). We would be overwhelmed by the vastness o...
Korbinian Koller | November 26, 2019 |

Gold Set to Correct but Internals Remain Bullish

Last week we wrote that near-term risk in precious metals (Gold and GDX especially) was rising and a correction could begin soon. As Gold nearly reached major resistance at $1550/oz, the miners already began to correct. That negative divergence is an ominous signal for the...
Jordan Roy-Byrne, CMT | August 21, 2019 |

Feb 12th 2020, Crypto Chartbook – Consistently extracting profits

Consistently extracting profits In our chartbook publication from last week we published a chart with entry levels as a guide on when to enter the market. Briefly after publication, the first low risk price level was approached. Consequently we posted a screen...
Korbinian Koller | February 12, 2020 |

Empower Clinics increases its digital presence

Empower Clinics Inc. (CSE:EPW) is a Canada-based integrated healthcare company with multi-disciplinary clinics in Canada and the United States. Empower is focused on growing its research and clinical trials segment and pursuing a greater digital presence with healthcare...
Coreena Robertson | August 31, 2023 |

Resonant's Cup Is Half-Empty. . .Or, Is It Half-Full?

You gotta love Resonant Inc. (RESN:NASDAQ) . It seems like every quarter the company misses earning projections, yet dangles a carrot so delicious that investors get distracted. Shorts have reason to feel good; so do the bulls. RESN is a great battleground stock where ...
Streetwise Reports | August 13, 2019 |

Silver’s Q4 Seasonal Outlook

What has been will be again, what has been done will be done again; there is nothing new under the sun. Ecclesiastes 1:9 History repeats itself. Not always, and not 100%, but often enough and to an extent that’s significant enough to make these repet...
Mike McAra | October 2, 2019 |

When Will it be Safe to Jump Back into the Gold and Silver Pool?

Once again the DSI (Daily Sentiment Indicator) made an accurate call on a major top in gold and silver. The DSI reached nosebleed territory for gold about four weeks ago suggesting the metals were nearing shoal waters. Silver and platinum got stupid a week ago and I su...
Streetwise Reports | September 13, 2019 |

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation

Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Produc...
Streetwise Reports | September 24, 2019 |

ResMed Shares Set 52-Week Intraday High Price After Posting Q1 Earnings

Shares of respiratory medical device maker and software applications company ResMed Inc. traded 15% higher at times today after the firm posted positive Q1/20 earnings results. Developer and manufacturer of medical devices and cloud-based software applications that di...
Streetwise Reports | October 26, 2019 |

Apellis Pharma Shares Rise 20% on Positive Top-line Data in Phase 3 PNH Trial

Shares of Apellis Pharmaceuticals opened 35% higher and established a new 52-week intraday high price today after the company announced positive top-line results from its Phase 3 head-to-head study of Pegcetacoplan (APL-2) versus Eculizumab in patients with Paroxysmal Nocturna...
Streetwise Reports | January 8, 2020 |
1 2 3 4